Real-world experience of teriflunomide in relapsing multiple sclerosis: paramagnetic rim lesions may play a role

ObjectivesThe aims of this study were to report the effectiveness and safety of teriflunomide in Chinese patients with relapsing–remitting multiple sclerosis (RRMS) and to explore the association of paramagnetic rim lesion (PRL) burden with patient outcome in the context of teriflunomide treatment a...

Descrición completa

Detalles Bibliográficos

Principais autores:	Hongmei Tan, Xiang Li, Yuxin Li, Fanru He, Jingzi ZhangBao, Lei Zhou, Liqin Yang, Chongbo Zhao, Chuanzhen Lu, Qiang Dong, Haiqing Li, Chao Quan
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Immunology
Assuntos:	multiple sclerosis magnetic resonance imaging teriflunomide paramagnetic rim lesion no evidence of disease activity
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1343531/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!